Unlabeled Multi-Dose Tirzepatide Vial Found in Medication Room
Penalty
Summary
Surveyors found that a multi-dose vial of Tirzepatide, a prescription medication used for type 2 diabetes and weight loss, was stored in the Unit One medication room without being labeled with the resident's name, the date it was opened, or the date it should be used by. Facility policy requires that all medications be stored in a safe, secure, and orderly manner, and that drug containers must have complete and legible labels, including the resident's name and relevant dates. During the observation, a registered nurse confirmed that the vial was opened and in use but lacked the required labeling. The Director of Nursing and Assistant Director of Nursing also confirmed that the vial was missing this information and acknowledged that it should have been properly labeled.